cd rom part one - Purdue University

cd rom part one - Purdue University

MULTIPARAMETER IMMUNOFLUORESCENCE Carleton C. Stewart, Ph.D. & Sigrid J. Stewart R ARKLL P aboratory Cancer Institute L OSWE of Flow Cytometry Department of Health, State of New York Elm and Carlton Streets Buffalo, New York 14263 phone: 716-648-5480 fax: 716-648-8806 email: [email protected] ANTIBODY BINDING TO CELLS RPCI LFC THE LAW OF MASS ACTION Ab + Ep Kf AbEp Kr A Ep AbEp Kf = Kr = b

AbEp A Ep b 6 K range is usually ~ 10 f Kr range is usually ~ 10 -3 Ka = Kf/Kr = 106/10-3 = 109 WAYS ANTIBODIES BIND TO CELLS Specific: Fab to epitope Fc to Fc receptor binding is high affinity and saturable Non Specific: binding is low affinity and not saturable Specific Activity is the concentration of bindable antibody to its epitope divided by the protein concentration. SA = [F(ab')2] (protein) Reasons Antibodies do not bind to cells: overconjugation not purified degradation of binding site aggregation STORING OF ANTIBODIES :

Proteases destroy antibodies in: ascitic fluid serum bacteria Use sodium azide Use highly purified albumin or gelatin as carrier Purify antibodies immediately TITERING ANTIBODIES RPCI LFC AMOUNT BOUND SPECIFIC ANTIBODY NON-SPECIFIC ANTIBODY CONCENTRATION 3 g s/n = 2.5 1 g s/n = 2.1 0.3 g s/n = 2.4 0.1 g s/n = 4.1 0.03 g s/n = 4.8 0.01 g s/n = 4.6

0.001 g s/n = 3.2 auto 3 0.003 g s/n = 3.5 5 Signal to Noise TITER 4 3 2 0 1 2 3 4 5 Dilution 6 7

8 number isotype control antibody 1 10 2 10 3 10 4 10 1 10 2 10 3 10 4 10 1 10 102 3 10

4 10 cytokeratin 1 g S/N Ab 278 IC 5.8 .3 g S/N Ab 100 IC 3.6 .01 g S/N Ab 25.7 IC 2.6 Signal to Noise 60 TITER 50 40 30 20 10 0 0 1 2 3

Dilution 4 5 6 number VERIFICATION OF ANTIBODY COMBINATIONS 10 1 10 2 FITC-CD3 10 33 10 4 10 1 10 2 PE-CD4 10 3 10 4 10 1 10 2 TC-CD8 10 3

10 4 10 10 CONTROL BATCH 4 4 CONTROL BATCH 10 10 3 3 R2 2 2 x = 69 y = 94 10 10 R1 10 10

x = 98 1 1 101 102 103 FITC-CD3 101 104 102 103 104 TC-CD8 10 10 PE- CD4 3 10 10 R2

2 10 2 x = 62 fail y = 96 pass 10 10 3 R1 PE-CD4 4 4 N EW BATCH 10 x = 97 pass 1 1 103 FITC-CD3 10 104

1 10 2 10 TC-CD8 3 10 4 D4 102 -CD4 101 BLOCKING IS IMPORTANT INDIRECT IMMUNOFLUORESCENCE STAINING NO BLOCKING Primary Antibody: murine monoclonal antibody Fc Fab Second Antibody: fluoresceinated goat anti-mouse IgG F(ab')2

FcR A epitope B C D ISOTYPE CONTROL- myeloma protein E F G AUTOFLUORESCENCE CONTROL H BLOCKING WITH GOAT IgG goat IgG add Mab Fab add fluoresceinated goat anti-mouse IgG F(ab')2 VERIFICATION OF BLOCK 1. FcR and non-specific binding FL-MAB + PE-mIgG 2. gIgG + FL-MAB + PE-mIgG LOG FLUORESCENCE EFFECT OF BLOCKING ON ANTIBODY BINDING TO MONONUCLEAR CELLS

CELL VOLUME number TOTAL A C B D channel number variation in gamma 1 myeloma protein binding to macrophages 50 45 40 35 30 25 20 15 10 5 0 0 17 39 4 23 mopc myeloma protein

13 21 log fluorescence Second Reagent Quality F(ab)2 of anti IgG anti IgG cell volume DEAD CELLS CAN BE A PROBLEM They bind antibodies non-specifically They masquerade as specific subsets They cause data misinterpretation ANTIBODIES BIND NONSPECIFICALLY TO DEAD CELLS PE-LAMBDA ALL CELLS VIABLE CELLS A B dead cells FL-KAPPA EMA PROCEDURE lysed, washed cells + 5 g EMA 18 cm.

1 2 10 min. WASH, FIX, AND ANALYZE 3 Evaluating Viability with Ethidium Monoazide % dead in gate = 1% % dead = 5% 4 120 10 SSC SSC 50 40 R9 30 30 40 50 60

70 80 90 100 FSC 120 10 20 Forward Scatter Height --> R9 20 10 Side Scatter Height --> FSC 120 60 100 70 90 Fluorescence Three Height -->

10 80 1 20 70 10 30 60 R2 80 40 50 2 50 40 10 60 30 100 90 70

20 Forward Scatter Height --> 3 80 10 10 100 90 R9 FL3-EMA 120 Side Scatter Height --> R9 R2 10 20 30 40 50 60 70

80 90 100 Forward Scatter Height --> FSC 120 ONE COLOR IMMUNOPHENOTYPING RPCI LFC SINGLE COLOR IMMUNOPHENOTYPING 1. IgG Block MAB wash FL-second antibody F(ab')2 wash 2. IgG Block B-MAB 3. IgG Block FL-MAB wash wash FL-Avidin wash CORRELATED (LIST MODE) DATA ACQUISITION Entry No. 1 2 3 4 5 6 7

8 k Value 80 100 40 20 90 120 100 110 50 75 110 120 Cell Number 1 1 1 1 2 2 2 2 n n n n Parameter FSC SSC Green Red FSC SSC Green Red

FSC SSC Green Red Analysis of List Mode Data A number of cells region A B C forward scatter CD4 fluorescence region B CD4 FLUORESCENCE region C STRATEGIES IN MULTICOLOR FLOW CYTOMETRY RPCI LFC CELLULAR ANTIGENS cytokines structure enzymes Adhesion Metabolic Receptors

courtesy of Jim Bender FLOW CYTOMETRY VS MICROSCOPIC IMAGING s o rt in g c e lls m o le c u lar qu an t it at io n an t ige n c o e xpre s s io n rare c e lls de t e c t io n c e llu lar i n t e rac t io n s pac ial re lat io n s h ips c o m part m e n t aliz at io n s ign al t o n o is e re je c t io n TWO COLOR IMMUNOPHENOTYPING Antibodies labeled with fluorescein Antibodies labeled with phycoerythrin RPCI LFC TWO COLOR IMMUNOPHENOTYPING 1. IgG Block + MAB wash FL- second antibody F(ab')2 IgG Block + PE-MAB wash wash 2. IgG Block + B-MAB + FL-MAB 3. IgG Block + FL-MAB + PE- MAB wash wash PE-Avidin

wash COMBINED INDIRECT AND DIRECT IMMUNOFLUORESCENCE STAINING Primary Antibody: mMAB NO BLOCKING Second Antibody: FGAM PE-mMAB NO BLOCK CD8 + FGAM 21% 6% 49% PE-CD4 VERIFICATION OF BLOCK Second Reagent Block gIgG + MAB wash FL-GAM wash PE-mIgG gIgG + MAB wash FL-GAM wash mIgG + PE-mIgG COMBINED INDIRECT AND DIRECT IMMUNOFLUORESCENCE STAINING Primary Antibody: mMAB BLOCKING Second Antibody: FGAM PE-mMAB CD8 + FGAM

BLOCKED 12% 42% PE-CD4 THREE COLOR IMMUNOPHENOTYPING Antibodies labeled with Fluorescein Antibodies labeled with Phycoerythrin Antibodies labeled with Tandem Complex to Avidin Tandem Complexes are Texas Red or CY 5 coupled to Phycoerythrin er CP is a natural Tandem Complex of peridinin and chlorophyll a protein SINGLE COLOR HISTOGRAMS FL2-CD4 CD4 --> 10 4 TWO COLOR PATTERN 10 3 color 10 2 CD3-CD4- black 1 CD3+CD4- blue

10 CD3-CD4+ cyan 10 1 10 2 CD3 --> 10 FL1-CD3 3 10 4 CD3+CD4+ green 10 2 1 10 CD4 --> CD4 2 10

1 10 10 3 10 4 10 3 CD8 --> 1 10 2 CD8 --> CD8 4 CD3 10 10 10 2 2

10 10 CD3 --> CD8 1 1 10 10 CD4 --> CD4 10 3 3 10 10 4 4 THREE COLOR PATTERN 10 1

10 2 CD3 --> 10 CD3 3 10 4 10 3 10 4 FOUR COLOR SINGLE LASER IMMUNOPHENOTYPING Antibodies labeled with fluorescein Antibodies labeled with phycoerythrin (PE) Antibodies labeled with PE/Texas Red Antibodies labeled with PE/CY5 or PerCP FOUR COLOR DUAL LASER IMMUNOPHENOTYPING Antibodies labeled with fluorescein Antibodies labeled with phycoerythrin (PE) Antibodies labeled with PE/CY5 or PerCP Antibodies labeled with APC, CY5 or CY7 3

CD4 10 2 10 CD3 --> 3 10 4 10 1 2 10 3 10 10 4 CD3 4 2 CD3 -->

10 10 3 4 CD3 3 10 10 3 10 3 1 10 2 CD56 --> 10 CD56 3 10 4

2 1 10 1 10 10 10 CD4 --> 2 10 CD4 --> 10 CD4 CD4 10 2 10 CD8 1 10 CD8 -->

10 1 10 CD3 4 10 CD3 --> 4 1 10 CD4 --> 1 10 1 10 10 10 2 10 3 2

10 CD8 --> 10 10 2 10 1 CD56 --> 10 10 CD8 3 CD56 10 4 4 4 FOUR COLOR PATTERN 10 1 10

2 CD56 --> 10 CD56 3 10 4 10 1 10 2 CD8 --> CD8 10 3 10 4 FL1 FL2 FL2

FL1 FL3 FL3 FL2 FL2 FL3 FL1 FL1 FL3 VISUALIZING EACH POPULATION FL4 FL4 FL1 FL3 FL2 FL3 FL3 FL1 FL2 FL4 4 COLOR FL2

3 COLOR 2 COLOR FL1 BIVARIATE DOT PLOTS CAN BE USED TO DISPLAY THE PATTERNS GENERATED BY MULTIPARAMETER DATA. UNDERSTANDING BINARY LOGIC IS USEFUL P1 + + + + + + + + P2 + + + + + + + + P3 + + + + + + + +

P4 + + + + + + + + P1 P2 P3 P4 Note that in binary logic the 1st parameter is sequenced as -/+, two parameters as --/++, 3 parameters as ----/++++, etc.. for as many parameters that are measured. The problem encountered after 3 parameters is...how does one visualize the multiple populations? COLOR PATTERNS USED TO VIEW COEXPRESSION A b 2 Ab3 Ab1 Ab1 ne eg .(-) os.(+) ne g.(-) no s.(+)

A b 1 A b 2 Ab2 neg.(-) neg.(-) pos.(+) pos.(+) Ab3 neg.(-) neg.(-) neg.(-) neg.(-) color grey yellow cyan green Ab1 neg.(-) pos.(+) neg.(-) pos.(+) Ab3 Ab2 neg.(-) neg.(-) pos.(+) pos.(+)

Ab3 pos.(+) pos.(+) pos.(+) pos.(+) color rust blue violet red Boolean Logic Table For Four Color Immunophenotyping R1 R2 R3 R4 bo o le an Ab1 Ab2 Ab3 Ab4 n o t (R1 o r R2 o r R3 o r R4 ) + R1 an d n o t (R2 o r R3 o r R4 ) + R2 an d n o t (R1 o r R3 o r R4 ) + + R1 an d R2 an d n o t (R3 o r R4 ) + R3 an d n o t (R1 o r R2 o r R4 ) + + R1 an d R3 an d n o t (R2 o r R4 ) + + R2 an d R3 an d n o t (R1 o r R4 ) + + + R1 an d R2 an d R3 an d n o t R4 + R4 an d n o t (R1 o r R2 o r R3 )

+ + R4 an d R1 an d n o t (R2 o r R3 ) + + R4 an d R2 an d n o t (R1 o r R3 ) + + + R4 an d R1 an d R2 an d n o t R3 + + R4 an d R3 an d n o t (R1 o r R2 ) + + + R4 an d R1 an d R3 an d n o t R2 + + + R4 an d R2 an d R3 an d n o t R1 + + + + R4 an d R2 an d R3 an d R1 Ab4 is t h e gat in g an t ibo dy c o lo r gre y y e llo w c y an gre e n ru s t blu e v io le t re d gre y y e llo w c y an gre e n ru s t blu e v io le t re d

Types of Antigen Expression B Ab1 Ab1 Ab1 F Ab2 E Ab2 Ab2 D Ab1 C Ab2 Ab2 Ab2 A Ab1 Ab1 INTERPRETING COEXPRESSION 4 10 C

D 1 9 A2 1 10 C D 1 9 3 10 2 10 CD19 --> 3 10 2 10 1 1 10 10

4 10 4 10 B 19 18 CD19 --> 3 1 10 2 CD7 --> CD7 5 10 3 10 20 4 4 10

C D 1 9 10 2 10 CD7 --> 21 10 C6 3 C D 7 4 1 10 2 CD2 --> CD2 1 10 3

10 4 D2 3 10 2 10 CD19 --> R1 1 1 10 10 7 8 10 1 10 2 CD2 --> CD2

10 3 10 4 3 4 10 1 10 2 CD7 --> CD7 10 3 10 4 THREE OR MORE COLOR IMMUNOPHENOTYPING wash 1. IgG Block + MAB Biotin- second antibody F(ab')2 wash wash IgG Block + FL- MAB + PE-MAB + TC- Avidin 2. IgG Block + FL-MAB + PE-MAB + B-MAB TC-Avidin

wash wash 3. IgG Block + FL-MAB + PE-MAB + TC-MAB wash TC (third color) = PE/TR or PE/CY5 tandem or PerCP STRATEGY FOR SELECTING FLUOROCHROME: EPITOPE DENSITY Low low-intermediate high FLUOROCHROME phycoerythrin, APC tandem, CY5 fluorescein, PerCP STAINING SOP 50 l washed, and blocked* whole blood or bone marrow lyse, centrifuge, decant, blot, and resuspend pellet Add antibody

combination 15 min. on ice *add 10 l mIg (10 mg/ml) to 1 ml washed whole blood. wash, fix, and analyse TANDEM COMPLEX PROPERTIES TO CONSIDER monocyte binding PE-CY5 light sensitivity PE-CY5 batch variation PE-TR and PE-CY5 Non-specific Binding to Monocytes B PerCP-CD4 C SSC CD25 CD25 A PE-CY5-CD4 FSC PE-fluorescence Effect of Light Exposure on PE-CY5 Tandem Fluorescence

TC-CD45 TC-CD3 PE-fluorescence EFFECT OF BATCH VARIATION 3 10 2 FL2-H --> 10 1 CD32 100 90 80 70 60 SSC-H --> 50 40 SSC 30 10 20 10

120 10 4 Fc Receptor Expression on Blood Leukocytes 10 20 30 40 50 60 70 80 FSC-H --> 90 100 120 10 10 2

FL1-H --> 10 3 10 4 10 4 CD16 1 10 2 10 3 CD64 FL3-H --> 10 4 3 10 2 10 1

FL1-H --> 10 10 CD16 3 10 2 FL2-H --> 10 1 10 CD32 10 10 4 4 FSC 1 10 1 10

2 FL3-H --> 10 3 CD64 1 10 10 2 FL1-H --> 3 10 2 10 FL1-H --> 3 10 3 2 1 10

10 4 1 10 2 FL1-H --> 10 10 3 4 10 1 10 1 10 2 10 2 FL3-H --> basophils

10 10 3 4 10 1 10 2 10 2 10 3 10 3 10 4 10 4 monocytes 10

1 2 FL3-H --> 10 10 3 4 10 3 2 1 10 10 4 10 FL2-H --> 10 10 10 1 2 10 FL1-H -->

10 3 10 4 NK cells FL3-H --> 10 10 3 4 3 10 10 1 10 2 FL3-H --> 3 10 4

10 10 1 2 FL1-H --> 10 10 3 4 CD16 10 3 10 4 10 1 10 1 2 10 2

10 3 10 4 10 3 10 4 10 2 FL3-H --> 10 CD64 3 10 4 10 2 FL1-H --> 10

CD16 3 10 4 3 10 2 10 FL2-H --> 1 1 CD32 10 10 10 2 10 FL2-H --> 1 1 CD32

10 2 10 10 3 3 10 4 10 10 FL3-H --> B-cells 4 10 2 10 FL2-H --> 10 FL1-H --> 1 CD32

1 10 4 10 3 10 2 FL2-H --> 10 1 CD32 10 10 2 1 10 10 4 T-cells 10 10 FL2-H --> 2

1 10 10 10 FL1-H --> 10 FL2-H --> 10 10 2 FL2-H --> 1 10 3 10 2 10 1 FL2-H --> 3 3 10

4 10 4 10 4 FL1-H --> 4 1 2 1 10 1 10 10 10 10 FL2-H --> 10 2 10 FL2-H -->

2 10 1 FL2-H --> 10 3 3 3 10 10 4 10 4 4 eosinophils 10 10 FL2-H --> 10 10 1

10 4 2 1 10 1 10 10 10 10 FL2-H --> 2 10 FL2-H --> 2 10 1 FL2-H --> 10 10 3

3 3 10 4 10 4 10 4 10 neutrophils 4 All Cells FL3-H --> CD64

Recently Viewed Presentations

  • Chapter 4

    Chapter 4

    PERT, which stands for Project Evaluation and Review Technique, was developed in the late 1950s to plan and control large weapons development projects for the U.S. Navy. The tools are not mutually exclusive (especially when PERT is based on "activity...
  • Peer to Peer Protocol CISC-856 TCP/IP & Upper

    Peer to Peer Protocol CISC-856 TCP/IP & Upper

    Gnutella 0.6 : Querying On connection client updates,supernode with all the files that the client shares. Client sends keyword query to supernode Supernode responds with matches. Supernode forwards query to other supernodes Client then selects files for downloading Peer to...
  • Eisenhower Presidency - Loudoun County Public Schools

    Eisenhower Presidency - Loudoun County Public Schools

    Seeds of Disquiet. Sputnik. October 4, 1957. 1st artificial satellite launched by Soviet Union. Nov 3, 1957. Launched another satellite, this time with a dog inside. US response. Dec 6. 1957 "flopnik" Doubled funds for missiles development. Lead to creation...
  • First Aid  The immediate, temporary care given to

    First Aid The immediate, temporary care given to

    Do not use ice! Cover the burn loosely with sterile gauze. ... A first aid procedure that combines rescue breathing and chest compressions to supply oxygen to the body. ... PowerPoint Presentation Last modified by:
  • Top Privacy Issues for Executive Directors of Family

    Top Privacy Issues for Executive Directors of Family

    Hopkins v. Kay 2015. The respondent, Erkenraadje Wensvoort, was one of 280 patients who had their health information improperly accessed and who were notified of the breach, as is required by PHIPA. The respondent had previously sought medical care for...
  • Expanding the Power of FBA for all Students

    Expanding the Power of FBA for all Students

    Social/Academic Instructional Groups (SAIG) Positive Behavior Interventions & Supports: A Response to Intervention (RtI) Model. Illinois PBIS Network, Revised October 2009. Adapted from T. Scott, 2004. Tier 2/ Secondary . Tier 3/ Tertiary. Intervention.
  • RoE - IIF

    RoE - IIF

    Title: RoE Author: home Last modified by: Radnoti Created Date: 5/8/2007 12:10:26 PM Document presentation format: Diavetítés a képernyőre (4:3 oldalarány)
  • HLA systém, jeho struktura a funkce HLA = human leukocyte ...

    HLA systém, jeho struktura a funkce HLA = human leukocyte ...

    HLA systém, jeho struktura a funkce HLA (Human Leukocyte Antigens ) = Hlavní histokompatibilní systém člověka 2. molekulárně-genetické metody 80. léta, technika PCR ( polymerace chain reaction ) 90. léta, typizace HLA antigenů II. třídy následně typizace HLA antigenů I....